IE820703L - Lyophilized preparation of a penicillin derivative - Google Patents

Lyophilized preparation of a penicillin derivative

Info

Publication number
IE820703L
IE820703L IE820703A IE70382A IE820703L IE 820703 L IE820703 L IE 820703L IE 820703 A IE820703 A IE 820703A IE 70382 A IE70382 A IE 70382A IE 820703 L IE820703 L IE 820703L
Authority
IE
Ireland
Prior art keywords
penicillin derivative
lyophilized
lyophilized preparation
concentration
product
Prior art date
Application number
IE820703A
Other versions
IE52936B1 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE820703(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IE820703L publication Critical patent/IE820703L/en
Publication of IE52936B1 publication Critical patent/IE52936B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Preparation of a pharmaceutical parenteral dosage unit of a lyophilized penicillin derivative in which the penicillin derivative is dissolved in water to a concentration of 100-135 mg/ml, as compared to the standard concentration of 200 mg/ml. The solution is then filled into a container and lyophilized by known techniques. The product is a light, fluffy lyophilized product which upon reconstitution will go into solution rapidly and completely even at the high concentration of 400 mg/ml. [GB2095551A]
IE703/82A 1981-03-26 1982-03-25 Composition of matter comprising a lyophilized preparation of a penicillin derivative IE52936B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26

Publications (2)

Publication Number Publication Date
IE820703L true IE820703L (en) 1982-09-26
IE52936B1 IE52936B1 (en) 1988-04-13

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
IE703/82A IE52936B1 (en) 1981-03-26 1982-03-25 Composition of matter comprising a lyophilized preparation of a penicillin derivative

Country Status (23)

Country Link
JP (1) JPS57159708A (en)
AT (1) AT395533B (en)
AU (1) AU549784B2 (en)
BE (1) BE892541A (en)
CA (1) CA1209477A (en)
CH (1) CH652306A5 (en)
DE (2) DE19375106I2 (en)
DK (1) DK157976C (en)
ES (1) ES509234A0 (en)
FR (1) FR2502624B1 (en)
GB (1) GB2095551B (en)
GR (1) GR78386B (en)
HK (1) HK39189A (en)
HU (1) HU186489B (en)
IE (1) IE52936B1 (en)
IL (1) IL64924A (en)
IT (1) IT1147916B (en)
LU (1) LU84031A1 (en)
NL (1) NL192664C (en)
NZ (1) NZ199632A (en)
PL (1) PL130564B1 (en)
SE (1) SE453153B (en)
ZA (1) ZA82605B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
BRPI0415531B8 (en) 2003-10-23 2021-05-25 Otsuka Pharma Co Ltd formulation of sterile injectable controlled-release aripiprazole and method for its preparation
ITMI20051630A1 (en) * 2005-09-02 2007-03-03 Acs Dobfar Spa INJECTABLE STERILE PHARMACEUTICAL FORMULATION CONTAINING AT LEAST TWO ACTIVE PRINCIPLES
LT2170279T (en) 2007-07-31 2018-03-12 Otsuka Pharmaceutical Co., Ltd. Methods for producing aripiprazole suspension and freeze-dried formulation
CN114200057A (en) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 Preparation method of antibiotic medicine solid mixed standard substance capable of replacing standard solution

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (en) * 1971-03-11 1974-03-15 Hoffmann La Roche PROCESS FOR THE PRODUCTION OF PENICILLOIC ACID DERIVATIVES.
JPS5817728B2 (en) * 1973-11-20 1983-04-09 山之内製薬株式会社 Ampicillin Sodium
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (en) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Process for the manufacture of sodium amphicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (en) * 1977-09-19 1979-04-13 Lafon Labor NEW PROCESS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC OR DIAGNOSIS FORMS
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (en) * 1979-06-21 1981-01-08 Basf Ag PREPARATION FOR SUBSTANCES, METHOD FOR THE PRODUCTION AND USE THEREOF

Also Published As

Publication number Publication date
IT8248034A0 (en) 1982-03-19
FR2502624B1 (en) 1985-10-25
GB2095551B (en) 1984-10-03
NL192664C (en) 1997-12-02
DK48382A (en) 1982-09-27
DK157976C (en) 1990-08-27
DE3208505A1 (en) 1982-10-21
JPS57159708A (en) 1982-10-01
CA1209477A (en) 1986-08-12
NZ199632A (en) 1985-07-12
AU549784B2 (en) 1986-02-13
IL64924A0 (en) 1982-04-30
IL64924A (en) 1985-07-31
IE52936B1 (en) 1988-04-13
BE892541A (en) 1982-09-20
HK39189A (en) 1989-05-19
ES8302455A1 (en) 1982-12-16
NL192664B (en) 1997-08-01
ES509234A0 (en) 1982-12-16
GB2095551A (en) 1982-10-06
PL235509A1 (en) 1982-12-20
SE453153B (en) 1988-01-18
CH652306A5 (en) 1985-11-15
LU84031A1 (en) 1982-07-08
NL8201251A (en) 1982-10-18
DK157976B (en) 1990-03-12
FR2502624A1 (en) 1982-10-01
ATA92982A (en) 1992-06-15
AT395533B (en) 1993-01-25
SE8200591L (en) 1982-09-27
AU7986582A (en) 1982-09-30
GR78386B (en) 1984-09-26
DE3208505C2 (en) 1991-11-28
DE19375106I2 (en) 2006-02-16
IT1147916B (en) 1986-11-26
ZA82605B (en) 1982-12-29
PL130564B1 (en) 1984-08-31
JPH0219804B2 (en) 1990-05-07
HU186489B (en) 1985-08-28

Similar Documents

Publication Publication Date Title
HU906341D0 (en) Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
IE872799L (en) Peptide preparation
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
EP0057360A3 (en) Cyclic carbonic acid derivatives, process for their preparation and their use as copolymerisation constituents for the preparation of polycarbonates
IL82209A0 (en) Insulin preparation
HUT51617A (en) Process for producing oxadiazole derivatives and pharmaceutical preparations containing these compounds as active substance
AU5328990A (en) A method of preparing a freeze-dried formulation containing a drug
AU3073789A (en) Drug delivery using pulmonary surfactant to facilitate absorption
DE2961284D1 (en) Tetrahydropyridinyl indole derivatives and their salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them
EP0243012A3 (en) Pyridyl-acrylic acid ester derivatives, process for their preparation and their use as fungicides
IE842618L (en) Sotrage of red blood cells
IE45439L (en) Penicillanic acid derivatives
HK39189A (en) Composition of matter comprising a lyophilized preparation of sodium piperacillin
PT75217B (en) Authoritative medicinal preparations of xanthine derivatives and method for their preparation
DE68914471D1 (en) Thieno [2,3-d] azepine derivatives, process for their preparation and pharmaceutical preparations containing them.
AU5077690A (en) Sodium n-acetylneuraminate trihydrate and method for the preparation thereof
HUT45256A (en) Process for producing 1,3,4,9-tetrahydropyrano/3,4-b/indol-1-acetic acid derivatives and pharmaceutical composition containing them
JPS5679622A (en) Antitumor pharmaceutical
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
DE3166925D1 (en) Products prepared from the thymic series factor or from its analogues and derivatives, process for preparation thereof, these products for use as medicines, radioactive tracers obtained from these products and use of these radioactive tracers in dosage processes
JPS6438026A (en) Glucide absorption inhibitor
IE34648L (en) Pharmaceutical composition containing garcinia acid
JPS646214A (en) Remedy for ulcerative colonopathy
SE8204792D0 (en) N-METHYL-D-GLUCAMINE SALT OF 3,4-DIHYDRO-5-METHYL-6- (2-METHYL-PROPYL) -4-OXOTIENO (2,3-D) PYRIMIDIN-2-CARBOXYLIC ACID AND PHARMACEUTICAL COMPOSITION CONTAINING THIS SALT